Cactus Semiconductor, Inc. is pleased to announce the introduction of our first ASSP (Application Specific Standard Product) developed for medical device designers and manufacturers to reduce risk and development time for implantable neurostimulation, neuromodulation, and other implantable pulse generator (IPG) applications. The CSI021 will be most beneficial to medical device manufacturers involved in peripheral nerve stimulation by providing a building block suitable for proof-of-concept, trials and even production; depending on the specific application.
Cactus Semiconductor’s CSI021 offers 4 stimulation channels with unlimited expansion capability; high voltage and high current outputs with integrated charge balancing. The device has an SPI Interface for programming, low overhead power and ultra-low standby power performance; all in an industry-leading 4mm x 4mm QFN package.
“Neurostimulation is a growing segment of the medical device market” says James McDonald, president of Cactus Semiconductor. “We felt this market segment was not being effectively served by other standard products on the market. The products available today do not adequately address the unique low power and performance requirements for this application space. The CSI021 will reduce risk and time to market challenges, especially for the many small and mid-size medical device companies who are developing new devices and therapies. Our decades of combined experience in designing and producing mixed-signal ICs for the medical market positions Cactus Semiconductor perfectly to help these customers build success and improve people’s lives.”
For more information, visit www.cactussemiconductor.com.